|
Patrick brings well over a decade of industry experience and expertise to GammaCan. Most recently, he served as Director of Investment Banking for Global Capital Markets Group, and prior to that as Director of Investment Banking at Rodman & Renshaw. In these posts, he led M&A and private transactions for a host of significant companies in the life sciences arena. Prior to entering the world of investment banking, Patrick acted as a buy-side analyst and portfolio manager for Mehta Partners, a leading healthcare focused hedge fund. He joined Mehta Partners after having worked for several years in the consulting industry with tenures at Booz Allen Hamilton’s New York healthcare practice and at Boston-based Global Prior Art, where he founded and fostered the growth of the company’s Life Science Practice for intellectual property consulting. The client roster included top tier pharmaceutical and biotechnology companies as well as some of the top US and EU IP law-firms.
Patrick graduated from Harvard Medical School and conducted extensive Ph.D. thesis research in the laboratory of Dr. Rudolf Jeanisch at the Whitehead Institute/M.I.T. He published his first peer-reviewed paper as an undergraduate and since then his work has been published in peer reviewed journals including Cell and Nature. | 